Valuation: Cipla Limited

Market Cap 1,120B 11.69B 10.19B 9.6B 8.74B 16.39B 16.41B 115B 44.3B 570B 43.9B 42.93B 1,841B P/E 2027 *
27x
P/E 2028 * 21.7x
Enterprise Value 1,014B 10.58B 9.23B 8.69B 7.91B 14.84B 14.85B 104B 40.11B 516B 39.75B 38.87B 1,666B EV / Sales 2027 *
3.27x
EV / Sales 2028 * 2.85x
Free-Float
68.87%
Yield 2027 *
0.94%
Yield 2028 * 1.06%
1 day-0.60%
1 week+1.47%
Current month-1.64%
1 month-3.22%
3 months+2.54%
6 months+10.32%
Current year-8.28%
1 week 1,344.3
Extreme 1344.3
1,405.2
1 month 1,344.3
Extreme 1344.3
1,442.3
Current year 1,165.7
Extreme 1165.7
1,539.7
1 year 1,165.7
Extreme 1165.7
1,673
3 years 1,132
Extreme 1132
1,702.05
5 years 850
Extreme 850
1,702.05
10 years 355.3
Extreme 355.3
1,702.05
Manager TitleAgeSince
Chief Executive Officer - 2026-03-31
Director of Finance/CFO - 2026-07-23
President - 2026-05-17
Director TitleAgeSince
Chairman 90 1972-07-20
Director/Board Member 72 2014-07-24
Director/Board Member 71 2021-06-29
Date Insider Type Main position Quantity % Market Cap. Importance
8/22/24 Sell 2,000 0.0002%
8/14/24 Sell 3,000 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
-0.60%+1.47%-12.04%+14.90% 11.74B
+1.72%+1.57%+12.86%+63.06% 45.94B
-1.02%-1.29%+36.59%+104.00% 37.22B
+0.09%+3.74%+11.93%+88.58% 12.06B
0.00%-0.95%+19.27%+142.99% 9.03B
+0.55%+2.71%+31.77%+42.86% 7.36B
+0.11%+1.27%+17.49%+196.00% 7.2B
-0.06%+2.20%+39.67%-16.79% 7.15B
+3.26%+3.77%-40.07%+13.57% 5.03B
-0.60%+0.25%+39.20%+105.61% 4.64B
Average +0.34%+1.71%+15.67%+75.48% 14.74B
Weighted average by Cap. +0.36%+0.49%+18.68%+77.81%

Financials

2027 *2028 *
Net sales 310B 3.23B 2.82B 2.66B 2.42B 4.54B 4.54B 31.81B 12.26B 158B 12.15B 11.88B 509B 347B 3.63B 3.16B 2.98B 2.71B 5.08B 5.09B 35.66B 13.74B 177B 13.62B 13.32B 571B
Net income 41.35B 432M 376M 354M 323M 605M 606M 4.25B 1.64B 21.07B 1.62B 1.59B 67.98B 51.42B 537M 468M 441M 401M 753M 754M 5.28B 2.03B 26.2B 2.02B 1.97B 84.53B
Net Debt -106B -1.11B -965M -909M -828M -1.55B -1.55B -10.89B -4.2B -54.03B -4.16B -4.07B -174B -131B -1.37B -1.2B -1.13B -1.03B -1.92B -1.93B -13.49B -5.2B -66.96B -5.15B -5.04B -216B
Logo Cipla Limited
Cipla specializes in development, manufacturing and marketing of pharmaceutical products. The group provides prescription products and OTC medicines for the treatment of cardiovascular, ophthalmic and dermatological diseases, respiratory troubles, cancers, allergies, infections etc. Besides, Cipla develops and sells veterinary products. Net sales by source of income break down between sale of products (96.9%) and services (3.1%). Net sales are distributed geographically as follows: India (39.4%), the United States (18.5%), South Africa (17%) and other (25.1%).
Employees
31,369
Date Price Change Volume
26-09-21 ₹1,386.10 -0.60% 895,131
26-09-18 ₹1,394.50 +1.32% 1,386,584
26-09-17 ₹1,376.30 +1.35% 730,653
26-09-16 ₹1,358.00 +0.52% 911,572
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
1,386.10INR
Average target price
1,509.08INR
Spread / Average Target
+8.87%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CIPLA Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!